logo
Volume 15 - Articles-1404                   MEJDS (2025) 15: 119 | Back to browse issues page

Ethics code: IR.US.PSYEDU.REC.1403.117

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Norouzi M, Sarafraz M R, Manouchehri M. The Lived Experience of Patients With Psychosomatic Disorders in the Transition From Biomedical to Psychological Treatment: A Qualitative Study. MEJDS 2025; 15 (0) :119-119
URL: http://jdisabilstud.org/article-1-3706-en.html
1- PhD Student in Psychology, Department of Psychology, Science and Research Branch, Islamic Azad University, Tehran, Iran
2- Associate Professor of Psychology, University of Shiraz, Shiraz, Iran
3- Assistant Professor, Tehran Medical Sciences Unit, Islamic Azad University, Tehran, Iran
Abstract:   (495 Views)

Abstract
Background & Objectives: Psychophysiological or psychosomatic disorders represent one of the most complex diagnostic and therapeutic areas in behavioral medicine, situated at the intersection of biomedical conceptualizations and emotion–focused psychotherapeutic models. Psychophysiological disorders not only cause chronic suffering and reduce quality of life but also increase healthcare system costs and challenge medical practitioners, especially when patients’ symptoms do not align with conventional medical findings. Patients frequently navigate long cycles of medical consultations, repeated diagnostic procedures, and inconclusive test results before receiving an accurate understanding of the emotional mechanisms contributing to their persistent somatic symptoms. Despite growing empirical evidence supporting the role of unconscious emotional processes, attachment patterns, and defensive functioning in the manifestation of bodily symptoms, the lived experience of these patients, particularly their transition from biomedical to psychotherapeutic care remains underexplored. The present study aimed to develop a conceptual model explaining the lived experience of individuals with psychosomatic symptoms during their journey from medical treatment to psychological therapy, with a focus on identifying structural, emotional, and relational factors that either maintain or reduce symptom persistence.
Methods: This qualitative study employed a Grounded theory approach to explore the dynamic processes shaping patients’ experiences. Twelve individuals with persistent somatic symptoms without identifiable organic pathology, all of whom had participated in psychotherapy, were recruited using purposive theoretical sampling. Drawing upon researchers’ experience in dynamic therapy, the study call was disseminated through a network of collaborators and specialists active in the field of emotion–focused therapies. Written or verbal informed consent was obtained from all participants. Data were collected through in–depth semi–structured interviews focusing on patients’ diagnostic journeys, encounters with medical professionals, emotional meaning–making of symptoms, and experiences in psychodynamic or emotion–focused therapy. Interviews were audio–recorded, transcribed verbatim, and analyzed using the constant comparative method across three stages: open, axial, and selective coding. Memos and analytic notes were used throughout the process to refine categories and explore emerging relationships. The analysis continued until theoretical saturation was reached. To enhance trustworthiness, strategies such as peer debriefing, member checking, audit trails of the analysis, and examination of discrepant cases were employed. Finally, the extracted categories were compared and integrated with the theoretical literature related to emotional dynamics, emotion processing mechanisms, and psychosomatic models, and the conceptual model was developed based on this integration. Ethical principles were fully observed, including informed consent and approval from the institutional ethics committee.
Results: Three core thematic axes emerged from the analysis. First was the healthcare system dynamics. Participants described contradictory diagnoses, fragmented care, and emotionally detached communication from providers as key contributors to confusion, anxiety, and diminished trust. Conversely, clear explanations, coordinated multidisciplinary care, and emotionally attuned interactions facilitated hope and engagement. The second was Individual emotional–personality factors, including chronic anxiety, insecure attachment patterns, fear of psychiatric medication, limited emotional awareness, and reliance on inhibitory defenses that were frequently linked to exacerbation of symptoms. Meaning–making how patients interpreted the bodily manifestations of their internal conflict played a central role in symptom intensity and their readiness for psychological treatment. The last one was social and familial support. Supportive family involvement reduced distress and fostered treatment engagement, while invalidation, stigma, or blame heightened symptom severity and reinforced feelings of helplessness.
Conclusion: According to the findings, the experience of psychosomatic patients results from the simultaneous interaction of healthcare system structures, an individual’s emotional capacities, and the quality of supportive relationships. Furthermore, achieving effective treatment necessitates an integrated, multidisciplinary approach that is sensitive to the emotional and cultural dimensions of patients.

Full-Text [PDF 357 kb]   (88 Downloads)    
Type of Study: Original Research Article | Subject: Psychology

References
1. Abbass A, Kisely S, Kroenke K. Short-term psychodynamic psychotherapy for somatic disorders. Psychother Psychosom. 2009;78(5):265–74. [DOI]
2. Ciechanowski P, Walker EA, Katon W. Attachment theory and somatization: an integrative review. Psychosom Med. 2002;64(6):660–7. [DOI]
3. Brown RJ. Psychological mechanisms of medically unexplained symptoms: an integrative conceptual model. Psychol Bull. 2004;130(5):793–812. [DOI]
4. Kroenke K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med. 2007;69(9):881–8. [DOI]
5. Kroenke K. Patients presenting with somatic complaints: epidemiology, psychiatric co‐morbidity and management. Int J Methods Psych Res. 2003;12(1):34–43. [DOI]
6. Wortman MSH, Van Der Wouden JC, Twisk JWR, Visser B, Assendelft WJJ, Van Der Horst HE, et al. Effectiveness of psychosomatic therapy for patients with persistent somatic symptoms: Results from the CORPUS randomised controlled trial in primary care. J Psychosom Res. 2023;167:111178. [DOI]
7. Creed F, Barsky A. A systematic review of the epidemiology of somatisation disorder and hypochondriasis. J Psychosom Res. 2004;56(4):391–408. [DOI]
8. Henningsen P, Gündel H, Kop WJ, Löwe B, Martin A, Rief W, et al. Persistent physical symptoms as perceptual dysregulation: a neuropsychobehavioral model and its clinical implications. Psychosom Med. 2018;80(5):422–31. [DOI]
9. Henningsen P. Still modern? developing the biopsychosocial model for the 21st century. J Psychosom Res. 2015;79(5):362–3. [DOI]
10. De Gucht V, Maes S. Explaining medically unexplained symptoms: toward a multidimensional, theory-based approach to somatization. J Psychosom Res. 2006;60(4):349–52. [DOI]
11. Leichsenring F. Effectiveness of long-term psychodynamic psychotherapy: a meta-analysis. JAMA. 2008;300(13):1551. [DOI]
12. Abbass A, Haghiri B. Intensive short-term dynamic psychotherapy for functional somatic disorders: a scoping review. Clin Neuropsychiatry. 2025;22(2):111–20. [DOI]
13. Kirmayer LJ, Young A. Culture and somatization: clinical, epidemiological, and ethnographic perspectives. Psychosom Med. 1998;60(4):420–30. [DOI]
14. Lane RD, Weihs KL, Herring A, Hishaw A, Smith R. Affective agnosia: expansion of the alexithymia construct and a new opportunity to integrate and extend Freud’s legacy. Neurosci Biobehav Rev. 2015;55:594–611. [DOI]
15. Wortman MSH, Olde Hartman TC, Van Der Wouden JC, Dankers S, Visser B, Assendelft WJJ, et al. Perceived working mechanisms of psychosomatic therapy in patients with persistent somatic symptoms in primary care: a qualitative study. BMJ Open. 2022;12(1):e057145. [DOI]
16. Torp NC, Højgaard DR, Aalberg M, Hybel KA, Skarphéðinsson GÁ, Thomsen PH, et al. The role of treatment expectations in predicting treatment outcomes: examining clinical and demographic influences. Nord J Psychiatry. 2025;79(6):462–71. [DOI]
17. Sharpe M, Carson A. “Unexplained” somatic symptoms, functional syndromes, and somatization: do we need a paradigm shift? Ann Intern Med. 2001;134(9):926–30. [DOI]
18. Kapos FP, Hoeger Bement M, Sluka KA. Social determinants and consequences of pain. J Pain. 2024;25(5):e145–e158.
19. Lumley MA, Schubiner H. Emotional awareness and expression therapy for chronic pain: rationale, principles and techniques, evidence, and critical review. Curr Rheumatol Rep. 2019;21(7):30. [DOI]
20. Uchino BN. Social support and health: a review of physiological processes potentially underlying links to disease outcomes. J Behav Med. 2006;29(4):377–87. [DOI]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.